Obesity, Metabolic Syndrome, and the Surgical Patient

Medical Clinics of North America

Volumn 93, Issue 5, 2009, Pages 1049-1063

  Levin, Phillip D ^a   Weissman, Charles ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bariatric surgery; Cardiovascular disease; Metabolic syndrome; Obesity; Obstructive sleep apnea; Preoperative evaluation

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; PLACEBO;

ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONVALESCENCE; DEEP VEIN THROMBOSIS; DIET THERAPY; DRUG WITHDRAWAL; DYSLIPIDEMIA; EPIDURAL ANESTHESIA; GLUCOSE INTOLERANCE; HEART INFARCTION; HUMAN; HYPERTENSION; INTUBATION; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LIPECTOMY; LIPOSUCTION; LIVER CIRRHOSIS; LIVER FIBROSIS; LOW DRUG DOSE; LUNG EMBOLISM; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; PERIOPERATIVE PERIOD; PNEUMATIC TOOL; PREVALENCE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SPINAL ANESTHESIA; SURGICAL PATIENT; SURGICAL STRESS; THROMBOSIS PREVENTION; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ADULT; CHILD; FEMALE; HEART DISEASES; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; PERIOPERATIVE CARE; RISK ASSESSMENT; SLEEP APNEA SYNDROMES; VENOUS THROMBOSIS;

EID: 68249143116     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2009.05.004     Document Type: Review

References (105)

1. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
2. Kahn R. Metabolic syndrome - what is the clinical usefulness?. Lancet 371 (2008) 1892-1893
3. Qiao Q., Gao W., Zhang L., et al. Metabolic syndrome and cardiovascular disease. Ann Clin Biochem 44 (2007) 232-263
4. Grundy S.M., Brewer H.B., Cleeman J.I., et al. Lenfant C for the conference participants' definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
5. Gendall K.A., Raingia S., Kennedy R., et al. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 50 (2007) 2223-2237
6. Mullen J.T., Davenport D.L., Hutter M.M., et al. Impact of body mass index on perioperative outcomes in patients undergoing major abdominal cancer surgery. Ann Surg Oncol 15 8 (2008) 2164-2172
7. Echahidi N., Pibarot P., Despres J.P., et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 50 (2007) 843-851
8. Yilmaz M.B., Guray U., Guray Y., et al. Metabolic syndrome negatively impacts early patency of saphenous vein grafts. Coron Artery Dis 17 (2006) 41-44
9. Kasai T., Miyauchi K., Kurata T., et al. Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J 70 (2006) 1531-1537
10. Kajimoto K., Kasai T., Miyauchi K., et al. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 72 (2008) 1481-1486
11. Tefekli A., Kertoglu H., Tepler K., et al. Does the metabolic syndrome or its components affect the outcome of percutaneous nephrolithotomy?. J Endourol 22 (2008) 35-40
12. Lindblad B.E., Hakabsson N., Phillipson B., et al. Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women. Ophthalmology 115 10 (2008) 1687-1692
13. Patel N., Bagan B., Vadera S., et al. Obesity and spine surgery: relation to perioperative complications. J Neurosurg Spine 6 (2007) 291-297
14. Ray J.G., Lonn E., Yi Q., et al. Venous thromboembolism in association with features of the metabolic syndrome. QJM 100 (2007) 679-684
15. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
16. Vijayaraghavan K., Jeffries M., Windsor M.L., et al. Metabolic syndrome and postoperative complications in cardiothoracic and vascular surgical and percutaneous interventions. J Am Osteopath Assoc 105 (2005) 27
17. Boden-Albala B., Sacco R.L., Lee H.S., et al. Metabolic syndrome and ischemic stroke risk. Stroke 39 (2008) 30-35
18. Wannamethee S.G., Shaper A.G., Lennon L., et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165 (2005) 2644-2650
19. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116 (2007) 1971-1996
20. Kuruba R., Koche L.S., and Murr M.M. Preoperative assessment and perioperative care of patients undergoing bariatric surgery. Med Clin North Am 91 (2007) 339-351 ix
21. Flemons W.W. Clinical practice: Obstructive sleep apnea. N Engl J Med 347 (2002) 498-504
22. Gross J.B., Bachenberg K.L., Benumof J.L., et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on perioperative management of patients with obstructive sleep apnea. Anesthesiology 104 (2006) 1081-1093
23. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
24. Fidan H., Fidan F., Unlu M., et al. Prevalence of sleep apnoea in patients undergoing operation. Sleep Breath 10 (2006) 161-165
25. Yegneswaran B., and Chung F. The importance of screening for obstructive sleep apnea before surgery. Sleep Med 107 3 (2008) 915-920
26. Chung F., Ward B., Ho J., et al. Preoperative identification of sleep apnea risk in elective surgical patients, using the Berlin questionnaire. J Clin Anesth 19 (2007) 130-134
27. Young T., Evans L., Finn L., et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20 (1997) 705-706
28. Strollo Jr. P.J., and Rogers R.M. Obstructive sleep apnea. N Engl J Med 334 (1996) 99-104
29. Cherniack N.S. Respiratory dysrhythmias during sleep. N Engl J Med 305 (1981) 325-330
30. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
31. Punjabi N.M., and Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99 (2005) 1998-2007
32. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 (2004) 521-530
33. Harsch I.A., Schahin S.P., Radespiel-Troger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 (2004) 156-162
34. Jean-Louis G., Zizi F., Clark L.T., et al. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 4 (2008) 261-272
35. Coughlin S.R., Mawdsley L., Mugarza J.A., et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
36. Chung F., Yegneswaran B., Liao P., et al. Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology 108 (2008) 822-830
37. Chung F., Yegneswaran B., Liao P., et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 108 (2008) 812-821
38. Gogenur I., Wildschiotz G., and Rosenberg J. Circadian distribution of sleep phases after major abdominal surgery. Br J Anaesth 100 (2008) 45-49
39. Knill R.L., Moote C.A., Skinner M.I., et al. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology 73 (1990) 52-61
40. Rosenberg J., Wildschiodtz G., Pedersen M.H., et al. Late postoperative nocturnal episodic hypoxaemia and associated sleep pattern. Br J Anaesth 72 (1994) 145-150
41. Gill N.P., Wright B., and Reilly C.S. Relationship between hypoxaemic and cardiac ischaemic events in the perioperative period. Br J Anaesth 68 (1992) 471-473
42. Reeder M.K., Muir A.D., Foex P., et al. Postoperative myocardial ischaemia: temporal association with nocturnal hypoxaemia. Br J Anaesth 67 (1991) 626-631
43. Mickelson S.A. Preoperative and postoperative management of obstructive sleep apnea patients. Otolaryngol Clin North Am 40 (2007) 877-889
44. Kim J.A., and Lee J.J. Preoperative predictors of difficult intubation in patients with obstructive sleep apnea syndrome. Can J Anaesth 53 (2006) 393-397
45. Ostermeier A.M., Roizen M.F., Hautkappe M., et al. Three sudden postoperative respiratory arrests associated with epidural opioids in patients with sleep apnea. Anesth Analg 85 (1997) 452-460
46. Nielsen K.C., Guller U., Steele S.M., et al. Influence of obesity on surgical regional anesthesia in the ambulatory setting: an analysis of 9038 blocks. Anesthesiology 102 (2005) 181-187
47. Kaw R., Michota F., Jaffer A., et al. Unrecognized sleep apnea in the surgical patient: implications for the perioperative setting. Chest 129 (2006) 198-205
48. Jones R.L., and Nzekwu M.M. The effects of body mass index on lung volumes. Chest 130 (2006) 827-833
49. Pelosi P., Croci M., Ravagnan I., et al. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg 87 (1998) 654-660
50. Hamoui N., Anthone G., and Crookes P.F. The value of pulmonary function testing prior to bariatric surgery. Obes Surg 16 (2006) 1570-1573
51. Nugent C., and Younossi Z.M. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 432-441
52. Angulo P., Hui J.M., Marchesini G., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45 (2007) 846-854
53. Jimba S., Nakagami T., Takahashi M., et al. Prevalence of nonalcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22 (2005) 1141-1145
54. Machado M., Marques-Vidal P., and Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45 (2006) 600-606
55. Dunn W., Xu R., Wingard D.L., et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103 (2008) 2263-2271
56. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
57. Dam-Larsen S., Franzmann M., Andersen I.B., et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53 (2004) 750-755
58. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44 (2006) 865-873
59. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
60. Targher G., and Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191 (2007) 235-240
61. Teh S.H., Nagorney D.M., Stevens S.R., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132 (2007) 1261-1269
62. Hoteit M.A., Ghazale A.H., Bain A.J., et al. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis. World J Gastroenterol 14 (2008) 1774-1780
63. Millwala F., Nguyen G.C., and Thuluvath P.J. Outcomes of patients with cirrhosis undergoing nonhepatic surgery: risk assessment and management. World J Gastroenterol 13 (2007) 4056-4063
64. Hansson P.O., Eriksson H., Welin L., et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med 159 (1999) 1886-1890
65. Goldhaber S.Z., Savage D.D., Garrison R.J., et al. Risk factors for pulmonary embolism: The Framingham Study. Am J Med 74 (1983) 1023-1028
66. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 381S-453S
67. Franchini M., Targher G., Montagnana M., et al. The metabolic syndrome and the risk of arterial and venous thrombosis. Thromb Res 122 6 (2008) 727-735
68. Prandoni P., Bilora F., Marchiori A., et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 348 (2003) 1435-1441
69. Ageno W., Becattini C., T' B., et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117 (2008) 93-102
70. Ay C., Tengler T., Vormittag R., et al. Venous thromboembolism-a manifestation of the metabolic syndrome. Haematologica 92 (2007) 374-380
71. Ageno W., Prandoni P., Romualdi E., et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 4 (2006) 1914-1918
72. Mismetti P., Laporte S., Darmon J.Y., et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88 (2001) 913-930
73. Poulose B.K., Griffin M.R., Zhu Y., et al. National analysis of adverse patient safety for events in bariatric surgery. Am Surg 71 (2005) 406-413
74. Gonzalez R., Haines K., Nelson L.G., et al. Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg Obes Relat Dis 2 (2006) 30-35
75. Prystowsky J.B., Morasch M.D., Eskandari M.K., et al. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery 138 (2005) 759-763
76. Roderick P., Ferris G., Wilson K., et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 9 (2005) iii-x 1
77. Frederiksen S.G., Hedenbro J.L., and Norgren L. Enoxaparin effect depends on body weight and current doses may be inadequate in obese patients. Br J Surg 90 (2003) 547-548
78. Shepherd F., Rosborough T.K., and Schwartz M.L. Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery. Obes Surg 14 (2004) 601-605
79. Quebbemann B., Akhondzadeh M., and Dallal R. Continuous intravenous heparin infusion prevents peri-operative thromboembolic events in bariatric surgery patients. Obes Surg 15 (2005) 1221-1224
80. Bult M.J.F., van Dalen T., and Muller A.F. Surgical treatment of obesity. Eur J Endocrinol 158 (2008) 135-145
81. Estaban-Varela J., Hinojosa M.W., and Nguyen N.T. Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic medical centers. Obes Surg 18 10 (2008) 1273-1277
82. Munoz R., Ibanez L., Salinas J., et al. Importance of routine preoperative upper GI endoscopy: why all patients should be evaluated?. Obes Surg 19 4 (2009) 427-431
83. Catheline J.M., Bihan H., Le Quang T., et al. Preoperative cardiac and pulmonary assessment in bariatric surgery. Obes Surg 18 (2008) 271-277
84. O-Keefe T., and Patterson E.J. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 14 (2004) 23-26
85. Salord N., Mayos M., Miralda R., et al. Respiratory sleep disturbances in patients undergoing gastric bypass surgery and their relation to metabolic syndrome. Obes Surg 19 1 (2009) 74-79
86. Ramaswamy A., Gonzalez R., and Smith C.D. Extensive preoperative testing is not necessary in morbidly obese patients undergoing gastric bypass. J Gastrointest Surg 8 (2004) 159-165
87. McCullough P.A., Gallagher M.J., deJong A.T., et al. Cardiorespiratory fitness and short-term complications after bariatric surgery. Chest 13 (2006) 517-525
88. Collazo-clavell M.L., Clark M., McAlpine D.E., et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc 81 10 Suppl (2006) S11-S17
89. Sjostrom L., Narbo K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
90. Kini S., Herron D.M., and Yanagisawa R.T. Bariatric surgery for morbid obesity - a cure for metabolic syndrome?. Med Clin North Am 91 (2007) 1255-1271
91. Chen S.B., Lee Y.C., Ser K.H., et al. Serum C-reactive protein and white blood cell count in morbidly obese surgical patients. Obes Surg 19 4 (2009) 461-466
92. Batsis J.A., Romero-Corral A., Collazo-Clavell M.L., et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled trial. Mayo Clin Proc 83 (2008) 897-907
93. Klein S., Fontana L., Young V.L., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 (2004) 2549-2557
94. Giugliano G., Nicoletti G., Grella E., et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 57 (2004) 190-194
95. Rizzo M.R., Paolisso G., Grella R., et al. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women?. Clin Endocrinol (Oxf) 63 (2005) 253-258
96. Tuttnauer A., and Levin P.D. Diabetes mellitus and anesthesia. Anesthesiol Clin 24 (2006) 579-597
97. Le Manach Y., Godet G., Coriat P., et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 104 (2007) 1326-1333 [table]
98. Pan W., Pintar T., Anton J., et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 (2004) II45-II49
99. Le Manach Y., Coriat P., Collard C.D., et al. Statin therapy within the perioperative period. Anesthesiology 108 (2008) 1141-1146
100. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
101. Lindenauer P.K., Pekow P., Wang K., et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291 (2004) 2092-2099
102. Hindler K., Shaw A.D., Samuels J., et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105 (2006) 1260-1272
103. Spencer F.A., Allegrone J., Goldberg R.J., et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 140 (2004) 857-866
104. Devereaux P.J., Yang H., Yusuf S., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
105. Sear J.W., Giles J.W., Howard-Alpe G., et al. Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified?. Br J Anaesth 101 (2008) 135-138